ConductScience.org, home
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)
API referenceFor AI assistants

Trial · NCT03043872

Results by group276

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 276

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Overall Survival (OS) in the Global Cohort; Assessed at Global Cohort Interim Analysis; D + EP Compared With EPGlobal Cohort: D + EP13.095% Confidence Interval 11.5 to 14.8months
Overall Survival (OS) in the Global Cohort; Assessed at Global Cohort Interim Analysis; D + EP Compared With EPGlobal Cohort: EP10.395% Confidence Interval 9.3 to 11.2months
OS in the Global Cohort; Assessed at Global Cohort Final Analysis; D + EP Compared With EP and D + T + EP Compared With EPGlobal Cohort: D + T + EP10.495% Confidence Interval 9.6 to 12.0months
OS in the Global Cohort; Assessed at Global Cohort Final Analysis; D + EP Compared With EP and D + T + EP Compared With EPGlobal Cohort: D + EP12.995% Confidence Interval 11.3 to 14.7months
OS in the Global Cohort; Assessed at Global Cohort Final Analysis; D + EP Compared With EP and D + T + EP Compared With EPGlobal Cohort: EP10.595% Confidence Interval 9.3 to 11.2months
OS in the China Cohort; Assessed at China Cohort First Analysis; D + EP Compared With EPChina Cohort: D + EP14.495% Confidence Interval 12.3 to NAmonths
OS in the China Cohort; Assessed at China Cohort First Analysis; D + EP Compared With EPChina Cohort: EP10.995% Confidence Interval 8.9 to 14.0months
OS in the China Cohort; Assessed at China Cohort Second Analysis; D + EP Compared With EP and D + T + EP Compared With EPChina Cohort: D + T + EP16.195% Confidence Interval 11.3 to 18.6months
OS in the China Cohort; Assessed at China Cohort Second Analysis; D + EP Compared With EP and D + T + EP Compared With EPChina Cohort: D + EP14.495% Confidence Interval 12.3 to 17.0months
OS in the China Cohort; Assessed at China Cohort Second Analysis; D + EP Compared With EP and D + T + EP Compared With EPChina Cohort: EP10.995% Confidence Interval 8.9 to 14.0months
OS in the Global Cohort; D + T + EP Compared With D + EPGlobal Cohort: D + T + EP10.495% Confidence Interval 9.6 to 12.0months
OS in the Global Cohort; D + T + EP Compared With D + EPGlobal Cohort: D + EP12.995% Confidence Interval 11.3 to 14.7months
Progression-Free Survival (PFS) in the Global CohortGlobal Cohort: D + T + EP4.995% Confidence Interval 4.7 to 5.9months
Progression-Free Survival (PFS) in the Global CohortGlobal Cohort: D + EP5.195% Confidence Interval 4.7 to 6.2months
Progression-Free Survival (PFS) in the Global CohortGlobal Cohort: EP5.495% Confidence Interval 4.8 to 6.2months
Objective Response Rate (ORR) in the Global CohortGlobal Cohort: D + T + EP74.2percentage of patients
Objective Response Rate (ORR) in the Global CohortGlobal Cohort: D + EP79.5percentage of patients
Objective Response Rate (ORR) in the Global CohortGlobal Cohort: EP70.6percentage of patients
Percentage of Patients Alive and Progression Free at 6 Months (APF6) in the Global CohortGlobal Cohort: D + T + EP43.295% Confidence Interval 37.1 to 49.1percentage of patients
Percentage of Patients Alive and Progression Free at 6 Months (APF6) in the Global CohortGlobal Cohort: D + EP45.495% Confidence Interval 39.3 to 51.3percentage of patients

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03043872/results

API referenceFor AI assistants